
|Articles|December 10, 2015
Podcast: FDA’s New Mobile Apps: Q&A with Paul Buckman
Advertisement
Paul Buckman (Director, Division of Online Communications, CDER, FDA) explains the impetus for FDA’s mobile apps and announces FDA’s newest mobile app,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
2
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
3
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5




